Brugada Syndrome Unmasked by Cellulitis of the Face

J Craniofac Surg. 2023 Jan-Feb;34(1):e41-e43. doi: 10.1097/SCS.0000000000008934. Epub 2022 Aug 15.

Abstract

A 35-year-old male patient with no specific history visited an emergency medical center with a chief complaint of facial swelling accompanied by fever (38.3°C). Contrast-enhanced facial computed tomography confirmed diffuse soft tissue swelling and facial infiltration of inflammation. Additional laboratory findings revealed elevated white blood cell count and C-reactive protein level. The patient also complained of chest pain; therefore, electrocardiography was performed, which confirmed a curved pattern-like ST-segment elevation (≥2 mm) of V2 without elevated cardiac enzyme levels. Based on various test results, the patient was diagnosed with Brugada syndrome. He was administered intravenous empirical antibiotics and intravenous ibuprofen as an antipyretic for the treatment of facial cellulitis and Brugada syndrome. After the resolution of the symptoms, his body temperature normalized. A subsequent electrocardiogram confirmed a normal sinus rhythm pattern. This case report shows that Brugada syndrome, a rare but life-threatening disease, can be unmasked by facial cellulitis. Because antipyretics can immediately reduce the critical rate of sudden cardiac death, Brugada syndrome should be differentially diagnosed, with an evaluation of facial cellulitis, to prevent sudden cardiac death.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brugada Syndrome* / diagnosis
  • Brugada Syndrome* / etiology
  • Brugada Syndrome* / therapy
  • Cellulitis / complications
  • Cellulitis / diagnosis
  • Cellulitis / drug therapy
  • Death, Sudden, Cardiac
  • Electrocardiography / adverse effects
  • Fever / etiology
  • Humans
  • Ibuprofen
  • Male

Substances

  • Ibuprofen